The Core Bio Genesis website.
Fundraising information.
In the internet jungle that we clear every day, start-ups hold the upper hand. It’s an idea that some will often work on for free for years, until maybe they find investors, a brand that buys them out, and when the millions come in, it’s called a unicorn.
Because there really aren’t that many. This is the case of the Strasbourg biotech start-up Core Biogenesis, yes said like that, it’s a bit like a British rock band or a science fiction film, so Core Biogenesis, which has just announced the closing of its first fundraising of funds to 10 million Euros. Okay, so why invest so much in this start-up? Because it intends to revolutionize the treatment of cancer and neurodegenerative diseases.
This fundraising will enable them to invest 6 million in a bioproduction site in Strasbourg and to industrialize its technology, which has the capacity to drastically reduce the cost of cell therapies. I won’t go into detail, it’s complex, but if you’re interested you can click on their website corebiogenesis.com, everything is very well explained: real Alsatian pride, and something to follow.